Skip to main content
NAR Cancer logoLink to NAR Cancer
. 2021 May 25;3(2):zcab020. doi: 10.1093/narcan/zcab020

Correction to ‘Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma’

Verónica Freire-Benéitez 1, Nicola Pomella 2, Thomas O Millner 3, Anaëlle A Dumas 4, Maria Victoria Niklison-Chirou 5,6, Eleni Maniati 7, Jun Wang 8, Vinothini Rajeeve 9, Pedro Cutillas 10, Silvia Marino 11,
PMCID: PMC8210015  PMID: 34319293

NAR Cancer, Volume 3, Issue 1, March 2021, zcab009, https://doi.org/10.1093/narcan/zcab009

The Authors wish to add new sources of Funding (in bold):

Contributor Information

Verónica Freire-Benéitez, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, E1 2AT, London, UK.

Nicola Pomella, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, E1 2AT, London, UK.

Thomas O Millner, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, E1 2AT, London, UK.

Anaëlle A Dumas, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, E1 2AT, London, UK.

Maria Victoria Niklison-Chirou, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, E1 2AT, London, UK; Centre for Therapeutic Innovation (CTI-Bath), Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK.

Eleni Maniati, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6AS, UK.

Jun Wang, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6AS, UK.

Vinothini Rajeeve, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6AS, UK.

Pedro Cutillas, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6AS, UK.

Silvia Marino, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, E1 2AT, London, UK.

FUNDING

Brain Tumour Research (Centre of Excellence award to S.M.); Barts Charity (Barts Brain Tumour Centre award to S.M.); The Brain Tumour Charity [GN-000389 to T.M.]; The Medical College of Saint Bartholomew's Hospital Trust (to A.A.D.). T.M. is a recipient of an NIHR clinical lectureship (CL-2019–19-001); funding from Cancer Research UK (centre award to Barts Cancer Institute) is also acknowledged.

The published article has been updated.


Articles from NAR Cancer are provided here courtesy of Oxford University Press

RESOURCES